Ulrike Krohn

发表

Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma – first analysis of toxicity and efficacy signals

C. Schmitt, L. Bullinger, J. Dürig, 2021, Leukemia & lymphoma.